145 related articles for article (PubMed ID: 35157271)
1. A Transgenic Heavy Chain IgG Mouse Platform as a Source of High Affinity Fully Human Single-Domain Antibodies for Therapeutic Applications.
Drabek D; Janssens R; van Haperen R; Grosveld F
Methods Mol Biol; 2022; 2446():121-141. PubMed ID: 35157271
[TBL] [Abstract][Full Text] [Related]
2. Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
Clarke SC; Ma B; Trinklein ND; Schellenberger U; Osborn MJ; Ouisse LH; Boudreau A; Davison LM; Harris KE; Ugamraj HS; Balasubramani A; Dang KH; Jorgensen B; Ogana HAN; Pham DT; Pratap PP; Sankaran P; Anegon I; van Schooten WC; Brüggemann M; Buelow R; Force Aldred S
Front Immunol; 2018; 9():3037. PubMed ID: 30666250
[TBL] [Abstract][Full Text] [Related]
3. Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct.
Henry KA; van Faassen H; Harcus D; Marcil A; Hill JJ; Muyldermans S; MacKenzie CR
Immunogenetics; 2019 Apr; 71(4):307-320. PubMed ID: 30656359
[TBL] [Abstract][Full Text] [Related]
4. Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies.
Schriewer L; Schütze K; Petry K; Hambach J; Fumey W; Koenigsdorf J; Baum N; Menzel S; Rissiek B; Riecken K; Fehse B; Röckendorf JL; Schmid J; Albrecht B; Pinnschmidt H; Ayuk F; Kröger N; Binder M; Schuch G; Hansen T; Haag F; Adam G; Koch-Nolte F; Bannas P
Theranostics; 2020; 10(6):2645-2658. PubMed ID: 32194826
[No Abstract] [Full Text] [Related]
5. Expression Cloning and Production of Human Heavy-Chain-Only Antibodies from Murine Transgenic Plasma Cells.
Drabek D; Janssens R; de Boer E; Rademaker R; Kloess J; Skehel J; Grosveld F
Front Immunol; 2016; 7():619. PubMed ID: 28066429
[TBL] [Abstract][Full Text] [Related]
6. Genetic removal of the CH1 exon leads to the production of hypofunctional heavy chain-only IgG2a in rats.
Li Z; Zhang M; Zheng S; Song Y; Cheng X; Yu D; Du L; Ren L; Han H; Zhao Y
Transgenic Res; 2020 Apr; 29(2):199-213. PubMed ID: 32078126
[TBL] [Abstract][Full Text] [Related]
7. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
Front Immunol; 2018; 9():2553. PubMed ID: 30524421
[TBL] [Abstract][Full Text] [Related]
8. Applications of High-Throughput DNA Sequencing to Single-Domain Antibody Discovery and Engineering.
Lowden MJ; Lei EK; Hussack G; Henry KA
Methods Mol Biol; 2023; 2702():489-540. PubMed ID: 37679637
[TBL] [Abstract][Full Text] [Related]
9. Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells.
Hellmann I; Waldmeier L; Bannwarth-Escher MC; Maslova K; Wolter FI; Grawunder U; Beerli RR
Front Immunol; 2018; 9():2490. PubMed ID: 30450096
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies.
Li X; Duan X; Yang K; Zhang W; Zhang C; Fu L; Ren Z; Wang C; Wu J; Lu R; Ye Y; He M; Nie C; Yang N; Wang J; Yang H; Liu X; Tan W
PLoS One; 2016; 11(9):e0161801. PubMed ID: 27588755
[TBL] [Abstract][Full Text] [Related]
11. Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice.
Zhang T; Cheng X; Yu D; Lin F; Hou N; Cheng X; Hao S; Wei J; Ma L; Fu Y; Ma Y; Ren L; Han H; Yu S; Yang X; Zhao Y
Front Immunol; 2018; 9():2202. PubMed ID: 30319646
[TBL] [Abstract][Full Text] [Related]
12. IgG variable region and VH CDR3 diversity in unimmunized mice analyzed by massively parallel sequencing.
Lu J; Panavas T; Thys K; Aerssens J; Naso M; Fisher J; Rycyzyn M; Sweet RW
Mol Immunol; 2014 Feb; 57(2):274-83. PubMed ID: 24211535
[TBL] [Abstract][Full Text] [Related]
13. A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire.
Deschacht N; De Groeve K; Vincke C; Raes G; De Baetselier P; Muyldermans S
J Immunol; 2010 May; 184(10):5696-704. PubMed ID: 20404276
[TBL] [Abstract][Full Text] [Related]
14. Next-Generation DNA Sequencing of V
Henry KA
Methods Mol Biol; 2018; 1701():425-446. PubMed ID: 29116520
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of effector functions related motifs, complement activation and hemagglutinating activities in Lama glama heavy chain antibodies.
Saccodossi N; De Simone EA; Leoni J
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):323-31. PubMed ID: 22197565
[TBL] [Abstract][Full Text] [Related]
16. A melanoma-specific VH antibody cloned from a fusion phage library of a vaccinated melanoma patient.
Cai X; Garen A
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6280-5. PubMed ID: 8692806
[TBL] [Abstract][Full Text] [Related]
17. Repertoire diversification in mice with an IgH-locus-targeted transgene for the rearranged VH domain of a physiologically selected anti-ssDNA antibody.
Li J; Geissal ED; Li W; Stollar BD
Mol Immunol; 2005 Aug; 42(12):1475-84. PubMed ID: 15950740
[TBL] [Abstract][Full Text] [Related]
18. Modulating antibody-dependent cellular cytotoxicity of epidermal growth factor receptor-specific heavy-chain antibodies through hinge engineering.
D'Eall C; Pon RA; Rossotti MA; Krahn N; Spearman M; Callaghan D; van Faassen H; Hussack G; Stetefeld J; Butler M; Durocher Y; Zhang J; Henry KA; Tanha J
Immunol Cell Biol; 2019 Jul; 97(6):526-537. PubMed ID: 30680791
[TBL] [Abstract][Full Text] [Related]
19. Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus.
Xu S; Yang H; Zhuo Y; Yu Y; Liao H; Li S; Yue Y; Su K; Zhang Z
Front Immunol; 2020; 11():632. PubMed ID: 32431693
[TBL] [Abstract][Full Text] [Related]
20. Isolation and optimization of camelid single-domain antibodies: Dirk Saerens' work on nanobodies.
Saerens D
World J Biol Chem; 2010 Jul; 1(7):235-8. PubMed ID: 21537479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
